SPPCP Research Forum
|
Track 1 |
Track 2 |
Mary Godsey, PharmD “Navigating Buprenorphine: Partial Agonist, Full Confusion – How Clinicians Navigate the Gray Areas of Pain Management” |
Neil K. Shah, PharmD, BCPS “Urgent opioid rotations to sublingual buprenorphine/naloxone (Suboxone) for pain and substance use disorder utilizing buprenorphine low dose initiations: a case series” |
Abigail Elizabeth Thomas, PharmD, RPh “Improving the Utilization of Opioid Management Agreements in Supportive Oncology: A Qualitative Improvement Project” |
Antoinette Nabukenya, PharmD “Evaluation of the Impact of Oral Ketamine on Opioid Requirements and Pain in Patients with Opioid Use Disorder” |
Mary Godsey, PharmD “Characteristics of Burnout Among Palliative Care Pharmacists” |
Kari Starbeck, PharmD “Medications for Opioid Use Disorder in Patients Discharging with a Referral to Hospice” |
Katelyn Kennedy, PharmD “Evaluation of Low-Dose Naltrexone Use for Chronic Pain Conditions in a Veteran Population” |
Oluchi Constance Onyenekwe, PharmD Candidate “Buprenorphine Transdermal Patches and Magnetic Resonance Imaging Safety” |
Katelyn Bye, PharmD “Improving Skeletal Muscle Relaxant Stewardship” |
Sydney White, PharmD “Evaluation of Buprenorphine Buccal Film and Transdermal Patch in the Treatment of Malignant Pain” |
Brooke J Brodzinski, PharmD “Integration of Palliative Pharmacists to Standard Oncologic Care of Patients with Head and Neck Cancer” |
|